Timothy P Fitzgerald
5PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 17, 2025
Patient Disease Characteristics and Treatment Patterns in Mild-Moderate Psoriasis: Results from Real-World Clinical Practice in the United States (PROSPECT Study).Emily J Goddard, James M Haughton, James E Lucas
|Dec 02, 2024
Comparison of On-Label Treatment Persistence in Real-World Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Interleukin-17A Inhibitors.Philip J Mease, Shannon A Ferrante, Natalie J Shiff
|Dec 30, 2022
Real-World Effectiveness of 9-12 Months of Guselkumab Therapy among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry.April W Armstrong, Timothy Fitzgerald, Robert R McLean
|Dec 09, 2022
Effectiveness of Guselkumab Therapy among Patients with Plaque Psoriasis with Baseline IGA Score ≥ 2 in the CorEvitas Psoriasis Registry.April W Armstrong, Timothy Fitzgerald, Robert R McLean
|Nov 25, 2021
Demographics, Disease Characteristics, and Patient-Reported Outcomes Among Patients with Psoriasis Who Initiated Guselkumab in CorEvitas' Psoriasis Registry.Jessica A Walsh, Kristina Callis Duffin, Abby S Van Voorhees
Pageof 1
Frequent Collaborators
1 joint publications
Philip J Mease
1 joint publications
Natalie J Shiff
1 joint publications
Soumya D Chakravarty
1 joint publications
Jessica A Walsh
1 joint publications
Emily J Goddard
1 joint publications
James M Haughton
1 joint publications
James E Lucas
1 joint publications
Sophie G Barlow
1 joint publications
Alexander M Litvintchouk
1 joint publications
David Wu
